Filter
1637
Filtered Results: 1637
Text search:
diagnóstico
molecular
Featured
Recommendations
190
New Publications
289
Language
Document type
No document type
707
Guidelines
402
Studies & Reports
272
Manuals
99
Strategic & Response Plan
79
Fact sheets
41
Training Material
16
Situation Updates
10
Resource Platforms
6
Infographics
4
Brochures
1
Countries / Regions
India
79
Latin America and the Carribbean
69
Western and Central Europe
54
Brazil
53
Global
52
Eastern Europe
35
Colombia
33
Africa
33
Kenya
25
Argentina
24
South Africa
22
Senegal
21
Peru
21
Tanzania
21
Ethiopia
19
El Salvador
17
West and Central Africa
17
Venezuela
16
Russia
16
Mozambique
15
Germany
15
East and Southern Africa
15
Paraguay
14
Congo, Democratic Republic of
13
Rwanda
11
Chile
11
Malawi
11
South–East Asia Region
11
Nigeria
10
Asia
10
Bolivia
10
Uganda
10
Sierra Leone
9
Cameroon
9
Philippines
9
Angola
9
Zambia
9
Ecuador
9
Ukraine
8
Burkina Faso
8
Liberia
8
Bangladesh
7
Ghana
6
Zimbabwe
6
Nepal
5
Benin
5
Guinea
5
Eastern Europe and Central Asia
5
Spain
5
Namibia
5
USA
4
Haiti
4
Middle East and North Africa
4
Western Pacific Region
4
North America
4
France
4
Côte d’Ivoire / Ivory Coast
4
Indonesia
4
Myanmar / Burma
4
Madagascar
4
Uruguay
3
Mali
3
Eswatini/ Swaziland
3
Pakistan
3
Guatemala
3
Mexico
2
Syria
2
Congo-Brazzaville
2
Niger
2
Italy
2
Cambodia
2
Dominican Republic
2
Guinea-Bissau
2
Lebanon
2
Georgia
2
Honduras
2
Chad
2
Tajikistan
1
Timor Leste/ East Timor
1
Thailand
1
Lesotho
1
Turkey
1
Gambia
1
Togo
1
China
1
Canada
1
Estonia
1
Burundi
1
Morocco
1
Mauritania
1
Jordan
1
Saudi Arabia
1
Luxembourg
1
Turkmenistan
1
Belgium
1
United Kingdom
1
Portugal
1
Nicaragua
1
Djibouti
1
Romania
1
Palestine
1
Central African Republic
1
Libya
1
Botswana
1
Iraq
1
Somalia
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
579
Clinical Guidelines
214
Pharmacy & Technologies
66
Public Health
58
Key Resources
24
Women & Child Health
19
Capacity Building
5
Toolboxes
TB
391
COVID-19
256
NTDs
139
AMR
98
Rapid Response
79
HIV
78
Mental Health
65
Ebola & Marburg
43
Zika
29
Pharmacy
25
Planetary Health
24
NCDs
17
Refugee
15
Polio
14
Caregiver
11
Health Financing Toolbox
8
Cholera
7
Specific Hazards
5
Global Health Education
5
Natural Hazards
4
Disability
4
Malaria
4
Conflict
3
The Global Programme on Tuberculosis & Lung Health of the World Health Organization (WHO/GTB) is now combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations pertaining to all areas related to the programmatic management of T...
Cystic fibrosis (CF) was earlier thought to be a disease prevalent in the West among Caucasians. However, quite a number of recent studies have uncovered CF cases outside of this region, and reported hundreds of unique and novel variant forms of CFTR. Here, we discuss the evidence of CF in parts of...
The Strategy provides a high-level unifying framework to leverage existing capacities, address barriers and strengthen the use of genomic surveillance in the detection, monitoring and response to public health threats. Genomic surveillance is part of the broader surveillance and laboratory system, a...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Monkeypox is an emerging viral zoonosis with symptoms similar to those observed in smallpox patients, although less severe. Since the global eradication of smallpox in 1980, monkeypox has emerged as the most important orthopoxvirus in humans. The Advisory Committee on Variola Virus Research (ACVVR) ...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta...
The current document is anupdate of the guidelines developed by the EUCAST subcommittee on detection of resistance mechanisms. The EUCAST Steering Committee has carried out the current update. The document has been developed mainly for routine use in clinical laboratories and doesnot cover technical...
This publication provides recommendations for the management of critically ill adult patients with COVID-19 being treated in intensive care units (ICUs) in the Americas. These clinical practice guidelines provide evidence-informed recommendations for identifying markers and mortality risk factors in...
Esta tercera versión resumida de la Guía para el cuidado de pacientes adultos críticos con COVID-19 en las Américas se elaboró con el objetivo de facilitar la consulta de las recomendaciones para el manejo de pacientes adultos críticos con COVID-19 atendidos en las unidades de cuidados intensi...
HAT diagnosis relies on laboratory techniques because clinical signs and symptoms are unspecific. Serodiagnostic tests exist only for Tbg and are based on the detection of specific antibodies, thus they are not confirmatory of infection. With the current low disease prevalence, the positive predicti...
HAT diagnosis relies on laboratory techniques because clinical signs and symptoms are unspecific. Serodiagnostic tests exist only for Tbg and are based on the detection of specific antibodies, thus they are not confirmatory of infection. With the current low disease prevalence, the positive predicti...
Guide de recommandations rapides 11 juin 2020
Depuis son identification en Chine en décembre 2019, le nouveau coronavirus responsable de la COVID‐19 s’est rapidement propagé pour causer une pandémie. Cette maladie se manifeste par des symptômes respiratoires non spécifiques de gravité var...
Ce guide sur la tuberculose résistante est un outil pratique destiné à aider les agents de santé à prendre en charge le malade du point de vue clinique et opérationnel en mettant l’accent sur la décision thérapeutique, la mise en œuvre et le suivi du régime court de 9 mois pour le traite...
Ce guide qui s’adresse à tous les prestataires de soins impliqués dans la prise en charge des enfants, peut être utilisé aussi bien au niveau des structures sanitaires publiques que privées.
Son objectif général est d’améliorer la prise en charge de la tuberculose de l’enfant au Sé...
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in response to requests from Member States, national pr...
Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19
recommended
ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to pr...
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e...
PLoS Negl Trop Dis 11(2): e0005356 -Published: February 23, 2017 21 pp
